Answers are grounded in this paper and cite their sources.
The coronavirus disease 2019 (COVID-19) can lead to serious health conditions thus vaccination is crucial, especially for elite athletes to avoid severe/prolonged symptoms after the coronavirus infection, which can significantly influence their sports performance. Yet, only a few studies examined immunization reactions after vaccination in elite athletes, and none in young athletes. Thus, we aimed to examine the prevalence and severity of any reactions after the Pfizer-BioNTech COVID-19 vaccine in young elite athletes. Local and systemic reactions were assessed two to three days after first vaccination in adolescent elite athletes. 15 different reactions, more local than systemic reactions, were reported. The most prevalent local reaction was injection site pain, and nearly 20% of the adolescents reported severe pain. In the case of systemic reactions, half of the adolescents reported mild/moderate fatigue, and one-third experienced mild/moderate muscle pain and/or headache. The most prevalent co-occurrence was between injection site pain, pain in extremity, fatigue and muscle pain. Young elite athletes tended to feel more pain and sensation, partly due to the fact that the systemic circulation of their skeletal muscle allows an advanced spread of the vaccine, causing stronger immune reactions. The network of the reported reactions may provide a clue for understanding the connections of local and systemic reactions. These findings show that the profile of post-vaccine reactions in young elite athletes can differ from that of the general population, which could be important for the timing of vaccination, the planning of pre/post-vaccination protocol, and for returning to normal training intensity.
No takes yet. Share an insight, caveat, or question.
Koller et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: